By
Adrianne Appel2024-11-06T20:14:00
A Texas health care organization agreed to pay $14.2 million to settle allegations it filed false claims related to violations of the “Stark” self-referral law, according to the Department of Justice (DOJ).
The Physician Self-referral Law, nicknamed after its author, former lawmaker Fortney “Pete” Stark (D-Calif.), prohibits doctors from referring Medicare patients to health care centers or services in which they have a financial interest.
Physicians working at Horizon Medical Center’s long term care facility allegedly violated the law by referring Medicare patients to any of three surgical outpatient centers, which, like the long-term care facility, were owned by Corinth Investor Holdings LLC.
2024-10-22T21:18:00Z By Adrianne Appel
Precision Toxicology has agreed to pay $27 million to settle allegations first brought by whistleblowers in three cases, that the company billed the federal government for unnecessary drug tests and paid kickbacks to doctors, the Department of Justice (DOJ) said.
2024-10-11T19:53:00Z By Adrianne Appel
Generic drug giant Teva Pharmaceuticals has agreed to pay $450 million to settle two cases brought by the Department of Justice (DOJ), including one alleging that co-pays it made on behalf of Medicare patients constituted illegal kickbacks, and a second action for alleged generic drug price fixing.
2024-08-23T13:10:00Z By Adrianne Appel
Home health and hospice agency Intrepid USA agreed to pay $3.8 million to settle allegations, first brought by four whistleblowers, that its facilities billed Medicare for services patients were not qualified to receive, according to the Department of Justice.
2025-11-17T21:10:00Z By Oscar Gonzalez
A probe into Fannie Mae uncovered compliance and governance concerns involving FHFA director Bill Pulte and other senior officials. The result, so far at least, was not to address the concerns uncovered but to fire staff in Fannie Mae’s ethics and internal investigations unit.
2025-11-13T20:34:00Z By Jaclyn Jaeger
The DOJ dropped a June 2024 indictment against a Cassava Sciences advisor, closing a case tied to an alleged short-selling scheme and related government probes. The case was criticized for fundamental flaws in evidence and legal procedures.
2025-11-10T21:16:00Z By Adrianne Appel
The former U.S. chief compliance officer of hedge fund firm Capula Investment Management has blown the whistle against his former employer, alleging he was terminated for raising concerns about improper expensing practices.
Site powered by Webvision Cloud